Creoptix ^Company

Creoptix is a private company based in Switzerland and the US that specializes in developing next-generation bioanalytical instruments for drug discovery and life sciences research. Their proprietary sensor and microfluidics technology, the Creoptix\xae WAVEsystem, provides high sensitivity and resolution to study biological interactions involving various molecules, including in biofluids like undiluted serum or plasma. The system uses Grating-Coupled Interferometry (GCI) technology to deliver high-quality kinetic data across a broader range of samples than traditional SPR equipment. Creoptix's tools enable life scientists to accelerate their discovery process.